510(k) K023296— COBAS INTEGRA ONLINE DAT II COCAINE II

Substantially Equivalent

Roche Diagnostics Corp.

Clearance details

Applicant: Roche Diagnostics Corp.
Product code: Code DIO
Advisory panel: Clinical Toxicology
Date received: 2002-10-02
Decision date: 2002-11-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.